Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Trends in preoperative weight loss modalities among patients receiving body contouring surgery
Liang J, Anderson JL, Cathey JM, et al.
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 2026
Semaglutide attenuates a proteomics-based dementia risk signature in older adults with overweight or obesity and cardiovascular disease without diabetes: A post hoc analysis of the SELECT phase 3 trial
Jiménez-Mausbach M, Tijms BM, Paterson C, et al.
Alzheimer's & dementia (Amsterdam, Netherlands), 2026;18(3):e70432
Microfluidic-assisted formulation of hydrophobic ion pairing-Based solid lipid nanoparticles for semaglutide delivery
Arduino I, Iacobazzi RM, Pontrelli A, et al.
International journal of pharmaceutics, 2026;:127291
Trends in glucagon-like peptide-1 receptor agonist utilization and expenditure in Croatia
Belančić A, Kučan Štiglić M, Fajkić A, et al.
The Journal of international medical research, 2026;54(8):3000605261470651
Impact of GLP-1 Analogue Therapy on Gastrointestinal Outcomes in Patients with Irritable Bowel Syndrome: A Real-World TriNetX Analysis
Khan SA, Marasini A, Shrestha A, et al.
Digestive diseases and sciences, 2026
Semaglutide Exposure During Pregnancy: Results from the FAERS Database
Zinzi A, Gaio M, Mascolo A, et al.
Pharmaceuticals (Basel, Switzerland), 2026;19(8)
GLP-1 Receptor Agonists in Obstructive Sleep Apnea: A Translational Perspective on Mechanisms and Clinical Implications
Gómez-Maldonado I, Rodríguez-Arana A, Tamayo-Pinzón A, et al.
International journal of molecular sciences, 2026;27(16)
Medication-overuse headache in migraine: could GLP-1 receptor agonists treat the addiction-like phenotype?
Pellesi L, Guerzoni S
Expert opinion on pharmacotherapy, 2026
Retatrutide: Obesity drug opens to “compassionate use” in US after speculation Trump took it
Brown C
BMJ (Clinical research ed.), 2026;394:e100530
Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis
Mann JFE, Badve SV, Baeres FMM, et al.
The lancet. Diabetes & endocrinology, 2026
One-year weight loss and metabolic outcomes after laparoscopic sleeve gastrectomy in adolescents compared with young adults: A propensity score-matched cohort study
Taki-Eldin A, Lotfy A, El-Soudani MSEM, et al.
Obesity pillars, 2026;19:100315
Out-of-Pocket Costs and Adherence to Semaglutide for Obesity Among Commercially Insured Adults
Shin E, Kim H, Lee J, et al.
JAMA health forum, 2026;7(8):e263113
Tirzepatide-Based Therapy for Multidomain Metabolic Improvement in an Active Duty Service Member: A Case Report
Kim SK
Cureus, 2026;18(8):e114114
Composition and Labelling Accuracy of Products Sold as Retatrutide in Australia
Piatkowski T, Craven A, Cornell S, et al.
Drug and alcohol review;45(6):e70231
Analysis of the efficacy and safety of liraglutide, semaglutide, and tirzepatide for the treatment of overweight and obesity: a systematic review and network meta-analysis
Pałka W, Moćko P, Śladowska K, et al.
Journal of endocrinological investigation, 2026
Correction: Revisional Metabolic and Bariatric Surgery Versus Semaglutide: Which Strategy Has Greater Efficacy for Recurrent Weigh Gain After Primary Bariatric Surgery?
Rivero-Moreno Y, Estrada A, Zamata-Ovalle D, et al.
Obesity surgery, 2026
Real-World Effectiveness and Treatment Patterns of Tirzepatide in a Large UK Digital Health Cohort
Rosenior-Patten O, Lees Z, Rowe R, et al.
Diabetes, obesity & metabolism, 2026
Safety of semaglutide on depressive symptoms among people with HIV in routine clinical care
Haidar L, Ruderman SA, Leong C, et al.
AIDS (London, England), 2026
Initiating semaglutide therapy reduces tobacco cigarette smoking intensity among people with HIV
Ruderman SA, Crane HM, Haidar L, et al.
AIDS (London, England), 2026
Endothelial Shear-Stress-Responsive Gene Adenylate Cyclase 4 Suppresses Atherosclerosis by Inhibiting cAMP/PKA-NF-κB Mediated Vascular Inflammation
Bao W, Xu J, Nian W, et al.
Arteriosclerosis, thrombosis, and vascular biology, 2026